Home

Champignon Brands (SHRM.C) announced their acquisition of British Columbia-based craft mushroom cultivator and supplier Artisan Growers earlier this week.

As we wait for the Canadian courts to repeat the process that made cannabis legal after decades in purgatory, some companies aren’t waiting around for their chance to claim a piece of the upcoming shroomaceuticals market.

As we wait for the Canadian courts to repeat the process that made cannabis legal after decades in purgatory, some companies aren’t waiting around for their chance to claim a piece of the upcoming shroomaceuticals market.

CBD product developer/retailer Yield Growth Corp (BOSS.C) has announced it has agreed to acquire 18% of Translational Life Sciences, a company that “aims to develop proprietary formulations using restricted substances to focus on unmet medical needs in opioid dependence, psychotic illness, pain management and traumatic brain injury, including concussion.”

50 years I’ve been bumbling around this planet, and the best damn weekend I’ve had on it to date occurred recently, under the influence of mushrooms.

On November 26, 2019  Absolem Health announced that it has entered into an L.O.I with Arev Brands (AREV.C) to “develop and produce mushroom extracts”, and potentially to collaborate to sell “mushroom-based products.”

With a stated mission of patients over profits, the Multidisciplinary Association for Psychedelic Studies (MAPS) is an outlier within the growing psychedelic treatment industry.

A 2015 study found by 2050, Earth will need to increase crop yields by between 60% and 110% to sustain a rapidly expanding human populace.

RLOVE is a new dating app designed “to connect awakened souls” who aren’t able to find partners through more traditional, tried and true means such as OkCupid.

When walking through the woods, or even a particularly grassy side street, it is not uncommon to see mushrooms of the same variety sprouting up through the undergrowth.

RethinkX, a think tank which analyzes industry-disrupting technologies, has published a report about new sources of protein at a time when hamburgers may be costlier than advertised.

Psilocybin and other psychedelics are forcing their way out of prohibition as potentially viable treatments for not only depression and anxiety but also Alzheimer’s and other neurodegenerative diseases plaguing millions in North America alone. In the end, psilocybin solutions address a $300 billion dollar psychotherapy and wellness global market.

Roadman Investments (LITT.V) is forming a California-based joint-venture with lifestyle centre Psychedelic Insights to open the first psilocybin therapy centre in the United States when the states get around to legalizing it.

The shroom-boom continues to develop as the City of Santa Cruz is the latest to decriminalize magic mushrooms.

Graph Blockchain’s (GBLC.C) story is either going to be one of ultimate failure—an object lesson of what not to do for new companies—or an absolutely great comeback story, but what’s obvious is that they’re not willing to fly the white flag anytime soon.

Flourish Mushroom Labs, a subsidiary of Yield Growth (BOSS.C), entered into a binding letter of intent with Acres Agricultural Canada to form a JV in Saint Vincent and the Grenadines for the cultivation of psilocybin mushrooms, and for research and development into compounds and therapeutic uses for psychedelic mushrooms.